Protein prenyl transferase inhibitors in the treatment of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/24 (2006.01) A61K 31/00 (2006.01) A61K 31/198 (2006.01) A61K 45/06 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2460057

A protein prenyl transferase inhibitor is used in the treatment of neuroinflammatory disease such as MS, uveitis, alzheimers or neuroAIDS. The inhibitor may be a combination of a farnesyl transferase inhibitor and a geranylgeranyl transferase inhibitor. Preferably, FTI-277 and/or GGTI-298 is employed.

L'invention concerne un inhibiteur de prényl-transférase protéique utilisé dans le traitement de maladies neuro-inflammatoires telles que la sclérose en plaques, l'uvéite, la maladie d'Alzheimer ou le neuro-sida. Cet inhibiteur peut être une combinaison d'un inhibiteur de farnésyl-transférase et d'un inhibiteur de géranylgéranyl-transférase. On utilise de préférence FTI-277 et/ou GGTI-298.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Protein prenyl transferase inhibitors in the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protein prenyl transferase inhibitors in the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein prenyl transferase inhibitors in the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1574688

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.